SCA
INSM icon

Snowden Capital Advisors’s Insmed INSM Stock Holding History

Snowden Capital Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Sell
7,262
-309
-4% -$37.4K 0.02% 673
2026
Q1 		$1.24M Buy
7,571
+337
+5% +$51.8K 0.03% 468
2025
Q4 		$1.26M Sell
7,234
-535
-7% -$97.6K 0.03% 452
2025
Q3 		$1.12M Buy
7,769
+46
+0.6% +$5.63K 0.03% 493
2025
Q2 		$777K Buy
7,723
+1,483
+24% +$113K 0.02% 598
2025
Q1 		$476K Sell
6,240
-362
-5% -$27.7K 0.02% 765
2024
Q4 		$456K Buy
6,602
+158
+2% +$11.4K 0.01% 808
2024
Q3 		$470K Buy
6,444
+416
+7% +$30.7K 0.01% 799
2024
Q2 		$404K Buy
+6,028
New +$234K 0.01% 850

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Snowden Capital Advisors's INSM Position: Q2 2026 in Review

Snowden Capital Advisors reduced its Insmed (INSM) stake by 4.1% in Q2 2026, selling an estimated $37.4K and leaving 7,262 shares worth $774K. The position accounts for 0.02% of the portfolio, ranked #673.

Snowden Capital Advisors first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Snowden Capital Advisors held 7,262 shares of Insmed worth $774K as of Q2 2026.
  • Snowden Capital Advisors sold 309 Insmed shares in Q2 2026, an estimated $37.4K.
  • Insmed made up 0.02% of Snowden Capital Advisors's portfolio in Q2 2026, its #673 holding.
  • Snowden Capital Advisors first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Snowden Capital Advisors's Insmed position peaked at $1.26M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.